Latest & greatest articles for prostate cancer

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on prostate cancer or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on prostate cancer and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for prostate cancer

189. Canadian Urological Association recommendations on prostate cancer screening and early diagnosis

Canadian Urological Association recommendations on prostate cancer screening and early diagnosis CUAJ • October 2017 • Volume 11, Issue 10 © 2017 Canadian Urological Association CUA GUIDELINE 298 Cite as: Can Urol Assoc J 2017;11(10):298-309. http://dx.doi.org/10.5489/cuaj.4888 See related editorial on page 295 Introduction Prostate cancer remains the most commonly diagnosed non- cutaneous malignancy among Canadian men and is the third leading cause of cancer-related death. In 2016 (...) , an estimated 21 600 men were diagnosed with prostate cancer and 4000 men died from the disease; 1 however, prostate cancer is a heterogeneous disease with a clinical course ranging from indolent to life-threatening. Identifying and treating men with clinically significant prostate cancer while avoiding the over-diagnosis and over- treatment of indolent disease remains a significant challenge. Several professional associations have developed guidelines on prostate cancer screening and early diagnosis

Canadian Urological Association2017

190. In localised prostate cancer, radical prostatectomy was associated with more sexual dysfunction and urinary incontinence than radiation or active surveillance

In localised prostate cancer, radical prostatectomy was associated with more sexual dysfunction and urinary incontinence than radiation or active surveillance In localised prostate cancer, radical prostatectomy was associated with more sexual dysfunction and urinary incontinence than radiation or active surveillance | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any (...) time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here In localised prostate cancer, radical prostatectomy was associated

Evidence-Based Medicine (Requires free registration)2017

191. Mindfulness-Based Cognitive Therapy in Advanced Prostate Cancer: A Randomized Controlled Trial

Mindfulness-Based Cognitive Therapy in Advanced Prostate Cancer: A Randomized Controlled Trial 27870567 2016 11 21 2017 01 17 1527-7755 35 3 2017 Jan 20 Journal of clinical oncology : official journal of the American Society of Clinical Oncology J. Clin. Oncol. Mindfulness-Based Cognitive Therapy in Advanced Prostate Cancer: A Randomized Controlled Trial. 291-297 10.1200/JCO.2016.68.8788 Purpose Advanced prostate cancer (PC) is associated with substantial psychosocial morbidity. We sought (...) to determine whether mindfulness-based cognitive therapy (MBCT) reduces distress in men with advanced PC. Methods Men with advanced PC (proven metastatic and/or castration-resistant biochemical progression) were randomly assigned to an 8-week, group-based MBCT intervention delivered by telephone (n = 94) or to minimally enhanced usual care (n = 95). Primary intervention outcomes were psychological distress, cancer-specific distress, and prostate-specific antigen anxiety. Mindfulness skills were assessed

EvidenceUpdates2017

197. Magnetic resonance imaging-guided in-bore biopsy for prostate cancer

Magnetic resonance imaging-guided in-bore biopsy for prostate cancer Magnetic resonance imaging–guided in-bore biopsy for prostate cancer Magnetic resonance imaging–guided in-bore biopsy for prostate cancer HAYES, Inc Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc. Magnetic resonance imaging–guided in-bore biopsy for prostate cancer. Lansdale: HAYES (...) , Inc. Directory Publication. 2017 Authors' conclusions Rationale: Targeted magnetic resonance imaging (MRI)-guided biopsy techniques, such as MRI-guided in-bore (MRI-IB) biopsy, have been developed to increase identification of clinically significant prostate cancer without increasing the detection of clinically nonsignificant tumors. Technology Description: MRI-IB biopsy is a technique that uses MRI images captured in real time and processed by interventional planning software to help insert

Health Technology Assessment (HTA) Database.2017

198. Irreversible electroporation for treating prostate cancer

Irreversible electroporation for treating prostate cancer Irre Irrev versible electropor ersible electroporation for treating prostate ation for treating prostate cancer cancer Interventional procedures guidance Published: 21 December 2016 nice.org.uk/guidance/ipg572 Y Y our responsibility our responsibility This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take (...) good relations. Nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. 1 1 Recommendations Recommendations 1.1 Current evidence on the safety and efficacy of irreversible electroporation for treating prostate cancer

National Institute for Health and Clinical Excellence - Interventional Procedures2017

199. In patients with localised prostate cancer, active surveillance is associated with better sexual function, urinary symptoms and bowel symptoms

In patients with localised prostate cancer, active surveillance is associated with better sexual function, urinary symptoms and bowel symptoms In patients with localised prostate cancer, active surveillance is associated with better sexual function, urinary symptoms and bowel symptoms | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we (...) use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here In patients with localised prostate cancer, active surveillance is associated with better sexual

Evidence-Based Medicine (Requires free registration)2017

200. Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis

Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis 27480976 2018 03 13 2018 11 13 2366-0058 42 1 2017 01 Abdominal radiology (New York) Abdom Radiol (NY) Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis. 271-277 10.1007/s00261-016-0851-3 Bone lesions on prostate MRI often raise concern about metastases. This study aimed to evaluate the prevalence (...) of bone metastases on staging prostate MRI and evaluate associations between their MRI features and clinical/pathologic characteristics. Retrospective, IRB-approved study of 3765 patients undergoing prostate MRI for newly diagnosed PCa between 2000 and 2014. The reference standard to calculate the prevalence of bone metastases was bone biopsy and/or ≥1-year follow-up after MRI. In a subsample of 228 patients, the MRI characteristics of bone lesions were recorded by two radiologists independently

Abdominal radiology (New York)2017 Full Text: Link to full Text with Trip Pro